Posted in | News | Electronics

Indium Corporation to Feature InFORMS® Reinforced Solder Preforms for IGBT Assembly at NEPCON Japan

Indium Corporation will feature its reinforced solder alloy fabrications, InFORMS®, for IGBT assembly at NEPCON Japan, January 15-17, Tokyo, Japan.

Uneven solder bondline thickness between the substrate and baseplate of an IGBT module can create areas of increased stress, leading to delamination and premature failure during the operational life of the module. Indium Corporation’s InFORMS® are a specially designed composite solder preform with a reinforcing matrix designed for all-around reliability. This results in:

  • Improved mechanical and thermal reliability
  • Uniform bondline thickness
  • Low-voiding performance

InFORMS® provide engineers with an enhanced material for the development of more reliable and higher performance modules. Due to the planarity improvements and stand-off tolerances, the package design becomes more predictable. In addition, stronger and more dependable joints allow for high power densities.

Source: www.indium.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Indium Corporation. (2019, November 21). Indium Corporation to Feature InFORMS® Reinforced Solder Preforms for IGBT Assembly at NEPCON Japan. AZoM. Retrieved on April 25, 2024 from https://www.azom.com/news.aspx?newsID=52592.

  • MLA

    Indium Corporation. "Indium Corporation to Feature InFORMS® Reinforced Solder Preforms for IGBT Assembly at NEPCON Japan". AZoM. 25 April 2024. <https://www.azom.com/news.aspx?newsID=52592>.

  • Chicago

    Indium Corporation. "Indium Corporation to Feature InFORMS® Reinforced Solder Preforms for IGBT Assembly at NEPCON Japan". AZoM. https://www.azom.com/news.aspx?newsID=52592. (accessed April 25, 2024).

  • Harvard

    Indium Corporation. 2019. Indium Corporation to Feature InFORMS® Reinforced Solder Preforms for IGBT Assembly at NEPCON Japan. AZoM, viewed 25 April 2024, https://www.azom.com/news.aspx?newsID=52592.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.